Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconIQVIqvia Holdings$30.58bn24.59n/a
us flag iconBNTXBioNTech SE$26.84bnn/an/a
us flag iconINSMInsmed$23.13bnn/an/a
us flag iconSMMTSummit Therapeutics$21.28bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconICLRIcon$12.32bn14.23n/a
us flag iconMEDPMedpace Holdings$12.20bn32.3n/a
us flag iconASNDAscendis Pharma A/S$11.68bnn/an/a
us flag iconTEMTempus AI$10.54bnn/an/a
us flag iconQGENQiagen NV$10.42bn24.67n/a
us flag iconEXELExelixis$10.15bn16.98n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconVRNAVerona Pharma$8.96bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconBPMCBlueprint Medicines$8.37bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$8.19bnn/an/a
us flag iconTECHBIO-TECHNE$7.90bn39.850.63%
us flag iconEXASExact Sciences$7.76bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$7.71bnn/an/a